MonoSol Rx Enters In
MonoSol Rx Enters Into Licensing Agreement With Vestiq Pharmaceuticals for Zuplenz(R) Oral Soluble Film
January 16, 2013 08:30 ET | MonoSol Rx
WARREN, N.J., Jan. 16, 2013 (GLOBE NEWSWIRE) -- MonoSol Rx, the developer of PharmFilm® drug delivery technology, today announced that it has licensed Zuplenz® (ondansetron) to Vestiq...
MonoSol Rx Acquires
MonoSol Rx Acquires U.S. Patent for Multifunctional Single Layer Film Drug Delivery Technology
December 20, 2012 10:00 ET | MonoSol Rx
WARREN, N.J., Dec. 20, 2012 (GLOBE NEWSWIRE) -- MonoSol Rx, the developer of PharmFilm® drug delivery technology, today announced it has acquired U.S. Patent #8,241,661, entitled "Biocompatible...
MonoSol Rx and Biond
MonoSol Rx and BiondVax Collaborate to Develop Oral Film Delivery of Flu Vaccine
November 07, 2012 08:45 ET | MonoSol Rx
WARREN, N.J., Nov. 7, 2012 (GLOBE NEWSWIRE) -- MonoSol Rx, LLC ("MonoSol Rx"), the developer of PharmFilm® drug delivery technology, announced today that it has entered into a partnership with...
MonoSol Rx Defeats B
MonoSol Rx Defeats BioDelivery Sciences International's Reexamination Challenges to MonoSol Rx's PharmFilm(R) Patents
October 16, 2012 17:02 ET | MonoSol Rx
WARREN, N.J., Oct. 16, 2012 (GLOBE NEWSWIRE) -- MonoSol Rx, LLC ("MonoSol Rx"), the developer of PharmFilm® drug delivery technology, announced today that challenges brought by MonoSol Rx...
MonoSol Rx Developin
MonoSol Rx Developing Migraine Product for Treatment of Pain and Nausea in a Single Dose
September 13, 2012 08:00 ET | MonoSol Rx
WARREN, N.J., Sept. 13, 2012 (GLOBE NEWSWIRE) -- MonoSol Rx, LLC ("MonoSol Rx"), the developer of PharmFilm® drug delivery technology, today announced that it is developing a new drug product for...
Midatech and MonoSol
Midatech and MonoSol Rx Announce Positive Phase 1 Clinical Results for Their Novel Transbuccal Oral Insulin Film Product
May 03, 2012 08:00 ET | MonoSol Rx
OXFORD, England and WARREN, N.J., May 3, 2012 (GLOBE NEWSWIRE) -- Midatech Ltd., a global leader in the design, synthesis and manufacture of nanomedicines based on its passivated gold-nanoparticle...
MonoSol Rx Remains C
MonoSol Rx Remains Confident in Patent Portfolio as Litigation Continues Against BioDelivery Sciences International
March 12, 2012 07:30 ET | MonoSol Rx
WARREN, N.J., March 12, 2012 (GLOBE NEWSWIRE) -- MonoSol Rx, LLC ("MonoSol Rx"), the developer of PharmFilm® drug delivery technology, will continue to defend its patent portfolio from attack by...
MonoSol Rx, LLC Rema
MonoSol Rx, LLC Remains Confident in Its Patent Portfolio
February 23, 2012 12:07 ET | MonoSol Rx
WARREN, N.J., Feb. 23, 2012 (GLOBE NEWSWIRE) -- MonoSol Rx, LLC ("MonoSol Rx"), the developer of PharmFilm® drug delivery technology, is preparing to defend its U.S. Patent No. 7,425,292 ("the...
MonoSol Rx and Midat
MonoSol Rx and Midatech Launch MidaSol Therapeutics LP
January 05, 2012 11:31 ET | MonoSol Rx
Strategic Initiative Focused on Partnering/Licensing of Innovative Diabetes Therapies Combines MonoSol Rx' Proprietary PharmFilm® and Midatech's Proprietary MidaForm™ Nanoparticle...
MonoSol Rx Announces
MonoSol Rx Announces Listing of Patent in FDA Orange Book for Suboxone(R) Sublingual Films
November 30, 2011 07:30 ET | MonoSol Rx
WARREN, N.J., Nov. 30, 2011 (GLOBE NEWSWIRE) -- MonoSol Rx, LLC ("MonoSol Rx"), the developer of PharmFilm® drug delivery technology and a drug delivery company specializing in film...